• Multiomics Platform Integration Advances Cancer Treatment Predictions

    Bio-IT World | A groundbreaking biotech collaboration in Switzerland has successfully integrated nine molecular analysis platforms to create a comprehensive tumor profiling system that predicts optimal cancer treatments—showcasing how next-generation sequencing can be enhanced through multiomics approaches for transformative clinical outcomes.

    Jul 24, 2025
  • Innovative Practices Award for NHS England, IQVIA Privacy Protection Platform

    Bio-IT World | To support patient privacy while providing data accessibility for organizations, the National Health Service (NHS) England with IQVIA developed NHS PET (Privacy Enhancing Technology) as a secure, scalable solution for patient data. The work earned NHS and IQVIA one of four Innovative Practices Awards at this year’s Bio-IT World Conference & Expo—an honor the judges christened the “Respect the Patient Award”.

    Jul 23, 2025
  • NIST Releases First Cancer Cell Line for Public Genomic Research

    Bio-IT World | The National Institute of Standards and Technology (NIST) has released the first cancer cell line in its Genome in a Bottle (GIAB) consortium. The new resource features a pancreatic cancer tumor cell line along with corresponding normal tissue samples, all obtained with explicit patient consent for public genomic data sharing.

    Jul 22, 2025
  • The New Frontier in Alzheimer’s Prevention: AI-Powered Neurodiagnostic Solutions

    Bio-IT World | Imagine sitting down for a routine checkup and learning you could prevent one of the most devastating diseases of our time before it ever occurs. For many families, diagnosis arrives only after noticeable confusion or memory loss disrupts daily life. By that point, much of the brain has already been damaged, and options for slowing decline are limited.

    Jul 18, 2025
  • A Popular Alzheimer’s Biomarker Found at High Levels in Newborns

    Bio-IT World | In recent years, phosphorylated tau has garnered so much attention as one of the “bad guys” of Alzheimer’s disease that the scientific community may have developed a bit of tunnel vision. A medical doctor in Sweden seeks to remedy the situation as a “champion” of the biomarker based on the critical if forgotten physiological role it plays in the healthy human brain.

    Jul 16, 2025